ASSET PURCHASE AGREEMENT BY AND BETWEEN SORRENTO THERAPEUTICS, INC., AND YUHAN CORPORATION DATED AS OF OCTOBER 30, 2023Asset Purchase Agreement • November 3rd, 2023 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of October 30, 2023 by and between SORRENTO THERAPEUTICS, INC., a Delaware corporation (“Seller”), and YUHAN CORPORATION, a Korean corporation (“Buyer”). Seller and Buyer are referred to herein each as a “Party” and together as the “Parties.” Capitalized terms used but not otherwise defined herein have the meanings set forth in Article I.
MANUFACTURING TECHNOLOGY TRANSFER AGREEMENTManufacturing Technology Transfer Agreement • November 3rd, 2023 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This MANUFACTURING TECHNOLOGY TRANSFER AGREEMENT (this “Agreement”) is made and entered into as of November 2, 2023 (the “Effective Date”) by and among SORRENTO THERAPEUTICS, INC., a Delaware corporation (“Seller”) and YUHAN CORPORATION, a Korean corporation (“Buyer”). Each of Seller and Buyer are referred to herein as a “Party” and together as the “Parties.”
